Publicaciones en las que colabora con José Carlos Subtil Íñigo (15)

2023

  1. Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinoma

    Pancreatology, Vol. 23, Núm. 4, pp. 411-419

2021

  1. Feasibility and patency of echoendoscopic anastomoses with lumen apposing metal stents depending on the gastrointestinal segment involved

    Scientific Reports, Vol. 11, Núm. 1

2019

  1. Neoadjuvant therapy for locally advanced gastric cancer patients. A population pharmacodynamic modeling

    PLoS ONE, Vol. 14, Núm. 5

  2. Use of machine-learning algorithms in intensified preoperative therapy of pancreatic cancer to predict individual risk of relapse

    Cancers, Vol. 11, Núm. 5

2018

  1. Intensified neoadjuvant multimodal approach in synchronous liver metastases from gastric cancer: a single institutional experience

    Clinical and Translational Oncology, Vol. 20, Núm. 5, pp. 658-665

2016

  1. Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer

    British Journal of Cancer, Vol. 115, Núm. 6, pp. 655-663

2013

  1. Estudio comparativo entre un colonoscopio con tecnología RIT ("responsive insertion technology") y un colonoscopio de rigidez variable convencional

    Revista Espanola de Enfermedades Digestivas, Vol. 105, Núm. 4, pp. 208-214

  2. Long-term follow-up study of gastroduodenal lesions after radioembolization of hepatic tumors

    World Journal of Gastroenterology, Vol. 19, Núm. 19, pp. 2935-2940

  3. Transanal endoscopic microsurgery for the treatment of a pararectal prostatic cancer recurrence

    Cirugia Espanola

2012

  1. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial

    International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593

2011

  1. Accuracy of endoscopic ultrasound to assess tumor response after neoadjuvant treatment in rectal cancer: Can we trust the findings?

    Diseases of the Colon and Rectum, Vol. 54, Núm. 9, pp. 1141-1146

2005

  1. Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas

    Journal of Clinical Oncology, Vol. 23, Núm. 5, pp. 999-1010

2004

  1. Gastric abscess

    Gastrointestinal Endoscopy, Vol. 59, Núm. 3, pp. 396-397

  2. Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors

    Journal of Clinical Oncology, Vol. 22, Núm. 8, pp. 1389-1397

2003

  1. Use of Colonoscopy as a Primary Screening Test for Colorectal Cancer in Average Risk People

    American Journal of Gastroenterology, Vol. 98, Núm. 12, pp. 2648-2654